The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vafseo
Vadadustat · VADADUSTAT 300 mg/1 · Tablet, Film Coated · Oral · Akebia Therapeutics, Inc.
NDC 59922-0642-60 · 1 BOTTLE in 1 CARTON / 60 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$2,556.00
Reported to Texas DSHS · 2026 annual filing · Akebia Therapeutics
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$0.137
HCPCS J0901 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$18,135
537 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · api manufacture
- Esteve Quimica, S.A.Spainanalysis · api manufacture
- Patheon Inc.Canadaanalysis · manufacture
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA215192
- TE code
- —
- Approval date
- Mar 27, 2024
- Patents / exclusivity
- 42 patents, 3 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NCE | Mar 27, 2029 |
| exclusivity | NCE | Mar 27, 2029 |
| exclusivity | NCE | Mar 27, 2029 |
| patent | 11324734 | Mar 31, 2036 |
| patent | 11324734 | Mar 31, 2036 |
| patent | 11844756 | Mar 31, 2036 |
| patent | 11844756 | Mar 31, 2036 |
| patent | 11844756 | Mar 31, 2036 |
| patent | 11324734 | Mar 31, 2036 |
| patent | 11065237 | Nov 14, 2034 |
| patent | 11065237 | Nov 14, 2034 |
| patent | 11065237 | Nov 14, 2034 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vadadustat (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Akebia Therapeutics, Inc. | VADADUSTAT 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Akebia Therapeutics, Inc. | VADADUSTAT 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Akebia Therapeutics, Inc. | VADADUSTAT 450 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vafseo — NDC 59922-0642-60," retrieved September 3, 2026, https://drugdashboards.com/drug/59922064260.
Free to cite with attribution — see how the data is put together.